Business● Low47m ago · Nov 12, 2026, 9:02 PM
Arrowhead Pharmaceuticals GAAP EPS of -$5.11 misses by $1.51, revenue of $450.82M misses by $13.32M
GlobeAlert Desk · curated from Seeking Alpha Tech · North America
Arrowhead Pharmaceuticals reported its GAAP EPS and revenue, both of which fell short of expectations. This provides an update on the company's financial performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
0 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Business
Not flagged as developing.
North America theater · last 7 days
rising · 28 in the last 24h1,803
events logged
98
risk index / 100
Wildfires 600Attacks & Assaults 488Robberies & Theft 374Shootings 224Rocket Launches 39
- Cyber activity (118 reports)Cyber Threats · United States · 2m ago
- Protest activity (140 reports)Protests · United States · 32m ago
- Conflict activity (169 reports)Conflict Events · United States · 1h ago
More in Business
Business15m agoAlmonty Industries GAAP EPS of C$0.17, revenue of C$41.89MSeeking Alpha TechBusiness15m agoGemini Space Station, Inc. reports Q3 resultsSeeking Alpha TechBusiness16m agoCerebras surges 18% after beating on quarterly revenue and announcing Microsoft dealCNBCBusiness16m agoNewsmax Inc. GAAP EPS of $0.12 beats by $0.13, revenue of $53.81M beats by $3.97MSeeking Alpha Tech